Scotland · NHS Scotland MSAN
Apomorphine hydrochloride (APO-go® PFS) 50mg/10ml solution for infusion
MSAN(2025)2 · Level 2 · issued 11 Jan 2025
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| Valid until: product is being discontinued | Discontinued | — |
| 1. APO-go® (apomorphine hydrochloride) PFS is being discontinued; supplies are anticipated to | Discontinued | — |
| cartridges remain available and can support increased demand. | Available | — |
| if Britannia nursing provision is available to provide training on new devices. | Available | — |
| Registration for access to the website is available to UK healthcare professionals and | Available | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.